BOOST-IC
@BOOSTICStudy
Followers
53
Following
58
Media
14
Statuses
67
Bringing Optimised COVID-19 vaccine Schedules To ImmunoCompromised populations (BOOST-IC): an adaptive randomised controlled clinical trial
Joined December 2022
#OpenAccess @BMC_series #Trials. #statstwitter looking for the details of how we’re analysing @BOOSTICStudy?. #BOOSTIC: Statistical elements and design, lead by @mdymock25 @drdavidwjg @j_h_mcmahon.@MonashUni @AlfredHealth .
0
1
4
Pleased to announce the publication of the #BOOSTIC protocol paper, describing how we’re exploring the role of booster doses of COVID-19 vaccines in immunocompromised hosts!. @drdavidwjg @j_h_mcmahon @OrlaMorris61218 @MonashUni @AlfredHealth @mdymock25.
trialsjournal.biomedcentral.com
Background Immunocompromised hosts (ICH) experience more breakthrough infections and worse clinical outcomes following infection with COVID-19 than immunocompetent people. Prophylactic monoclonal...
0
0
2
RT @JoshuaHillMD: In follow up to our first study we report the final analysis from the @CIBMTR @BMTCTN study of….
0
5
0
🚨BOOST-IC enrolled its 300th participant today!🚨. Well done to all our collaborators and thank you to our participants. 🥳👏🏻🎉. @AlfredHealth @MonashUni @TSANZ_txsoc @ALLGtrials @nhmrc #MRFF @ASHMMedia
0
2
2
Great summary on Flu and other vaccines for winter from @peripatetical Thanks Allen! Get your Flu and COVID-19 vaccines this year💉💉Winter's coming! 🌧️🌩️.
theguardian.com
With the flu season starting and peaking earlier, there have been several enhancements to influenza vaccines. What are they? And which one should you get?
1
1
2
285 participants enrolled in #BOOSTIC. Don’t forget, you can keep up to date on enrollment and access information for consumers, HCWs and about our study design on the BOOST-IC website (
0
0
0
Thanks for highlighting this @EricTopol need to watch BA.2.87.1
biorxiv.org
Newly emerged SARS-CoV-2 variants like JN.1, and more recently, the hypermutated BA.2.87.1, have raised global concern. We recruited two groups of participants who had BA.5/BF.7 breakthrough infect...
0
0
1
RT @drdavidwjg: 274 people are currently participating in @BOOSTICStudy across 11 sites in Australia, trying to understand and fine tune #C….
0
1
0
XBB.1.5 monovalent vaccine effectiveness against hospitalisation? 2 papers out in @TheLancetInfDis from @C_HHansen and @Eurosurveillanc from @hvwerkhoven 70-75% effectiveness in those > 60 yrs old. Get boosted!.
eurosurveillance.org
We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5 vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) in previously...
1
2
2
Amazing day @BOOSTICStudy 👋👋 260 people enrolled!! Congratulations What a team of investigators and participants @TSANZ_txsoc @ALLGtrials @ASHMMedia @MonashUni
0
1
1
RT @j_h_mcmahon: Now hiring to a project officer role for the PROPHECY study. Large MRFF funded clinical and scientific collaboration study….
monash.edu
0
5
0
RT @VictorianCHO: In recent weeks there has been a rapid increase in people with COVID in hospital. Learn how to protect those most at risk….
0
111
0
COVID-19 XBB.1.5 vaccines now being administered in @BOOSTICStudy 💉 Congrats to the first sites to achieve this @AlfredHealth @MonashHealth @pahospital 🙏 Amazing work from these sites and all sites enrolling 👏👏👏.
0
2
4
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
health.gov.au
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.
1
1
0
RT @j_h_mcmahon: 🥵 off the press!! New COVID vaccine recs from ATAGI.
health.gov.au
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.
0
3
0
Onwards and upwards for BOOST-IC. Huge thanks to all of our participants and sites 🙏. And now XBB.1.5 waiting in the wings. 💉🧚
0
2
3
Remarkable to look at COVID booster recs in different countries ATM. Everyone > 5 years in the US with an updated vaccine from @CDCgov compared to all over 75 and adults with severe immunocompromise from ATAGI @healthgovau 😯💉.
health.gov.au
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding an additional COVID-19 dose for highest risk people in 2023. These recommendations are in addition to...
0
2
3
Congrats to @pahospital on the recruitment of their first participant to @BOOSTICStudy!👏 . Great to have you on board in this important study.
Very excited to be welcoming @pahospital and the Haematology team to start recruitment for @BOOSTICStudy 👏 👏Thanks to @mollee_peter @ALLGtrials and the whole team!.
0
0
2